B-Type Natriuretic Peptide: An Emerging Biomarker in Pediatric Critical Care

  • P. E. Oishi
  • J. -H. Hsu
  • J. R. Fineman
Conference paper


In 1988, Sudoh and colleagues described a novel natriuretic peptide in porcine brain [1]. Subsequent studies found that brain natriuretic peptide was most abundant in the heart, and thus it was termed B-type natriuretic peptide (BNP). The release of BNP is triggered in large part by myocyte stretch and BNP levels are easily quantified by several commercially available assays. Thus, over the past decade numerous investigators sought to determine the clinical utility of BNP and together have now firmly established a role for BNP as a biomarker for diagnosis, prognostication, and management of adults with cardiac disease [2]. Unfortunately, far fewer data are available on the role of BNP in the management of critically ill neonates, infants, and children. Potential uses for BNP in pediatric critical care are outlined in Table 1. This chapter will provide a brief review of these data with the goal of helping clinicians make use of BNP in the care of these patients.


Natriuretic Peptide Kawasaki Disease Brain Natriuretic Peptide Patent Ductus Arteriosus Plasma Brain Natriuretic Peptide 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Sudoh T, Kangawa K, Minamino N, Matsuo H (1988) A new natriuretic peptide in porcine brain. Nature 332: 78–81PubMedCrossRefGoogle Scholar
  2. 2.
    Silver MA, Maisel A, Yancy CW, et al (2004) BNP Consensus Panel 2004: A clinical approach for the diagnostic, prognostic, screening, treatment monitoring, and therapeutic roles of natriuretic peptides in cardiovascular diseases. Congest Heart Fail 10: 1–30CrossRefGoogle Scholar
  3. 3.
    de Bold AJ, Borenstein HB, Veress AT, Sonnenberg H (1981) A rapid and potent natriuretic response to intravenous injection of atrial myocardial extract in rats. Life Sci 28: 89–94PubMedCrossRefGoogle Scholar
  4. 4.
    Levin ER, Gardner DG, Samson WK (1998) Natriuretic peptides. N Engl J Med 339: 321–328PubMedCrossRefGoogle Scholar
  5. 5.
    McGrath MF, de Bold ML, de Bold AJ (2005) The endocrine function of the heart. Trends Endocrinol Metab 16: 469–477PubMedCrossRefGoogle Scholar
  6. 6.
    Yandle TG (1994) Biochemistry of natriuretic peptides. J Intern Med 235: 561–576PubMedGoogle Scholar
  7. 7.
    Zhang Y, Carreras D, de Bold AJ (2003) Discoordinate re-expression of cardiac fetal genes in N(omega)-nitro-L-arginine methyl ester (L-NAME) hypertension. Cardiovasc Res 57: 158–167PubMedCrossRefGoogle Scholar
  8. 8.
    Hama N, Itoh H, Shirakami G, et al (1995) Rapid ventricular induction of brain natriuretic peptide gene expression in experimental acute myocardial infarction. Circulation 92: 1558–1564PubMedGoogle Scholar
  9. 9.
    Costello JM, Goodman DM, Green TP (2006) A review of the natriuretic hormone system’s diagnostic and therapeutic potential in critically ill children. Pediatr Crit Care Med 7: 308–318PubMedCrossRefGoogle Scholar
  10. 10.
    Koch A, Singer H (2003) Normal values of B type natriuretic peptide in infants, children, and adolescents. Heart 89: 875–878PubMedCrossRefGoogle Scholar
  11. 11.
    Yoshibayashi M, Kamiya T, Saito Y, et al (1995) Plasma brain natriuretic peptide concentrations in healthy children from birth to adolescence: marked and rapid increase after birth. Eur J Endocrinol 133: 207–209PubMedCrossRefGoogle Scholar
  12. 12.
    Ationu A, Carter ND (1993) Brain and atrial natriuretic peptide plasma concentrations in normal healthy children. Br J Biomed Sci 50: 92–95PubMedGoogle Scholar
  13. 13.
    Troughton RW, Frampton CM, Yandle TG, Espiner EA, Nicholls MG, Richards AM (2000) Treatment of heart failure guided by plasma aminoterminal brain natriuretic peptide (N-BNP) concentrations. Lancet 355: 1126–1130PubMedCrossRefGoogle Scholar
  14. 14.
    Maisel AS, Krishnaswamy P, Nowak RM, et al (2002) Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure. N Engl J Med 347: 161–167PubMedCrossRefGoogle Scholar
  15. 15.
    Murdoch DR, McDonagh TA, Byrne J, et al (1999) Titration of vasodilator therapy in chronic heart failure according to plasma brain natriuretic peptide concentration: randomized comparison of the hemodynamic and neuroendocrine effects of tailored versus empirical therapy. Am Heart J 138: 1126–1132PubMedCrossRefGoogle Scholar
  16. 16.
    Law YM, Keller BB, Feingold BM, Boyle GJ (2005) Usefulness of plasma B-type natriuretic peptide to identify ventricular dysfunction in pediatric and adult patients with congenital heart disease. Am J Cardiol 95: 474–478PubMedCrossRefGoogle Scholar
  17. 17.
    Cowley CG, Bradley JD, Shaddy RE (2004) B-type natriuretic peptide levels in congenital heart disease. Pediatr Cardiol 25: 336–340PubMedCrossRefGoogle Scholar
  18. 18.
    Koch A, Kitzsteiner T, Zink S, Cesnjevar R, Singer H (2007) Impact of cardiac surgery on plasma levels of B-type natriuretic peptide in children with congenital heart disease. Int J Cardiol 114: 339–344PubMedCrossRefGoogle Scholar
  19. 19.
    Gessler P, Knirsch W, Schmitt B, Rousson V, von Eckardstein A (2006) Prognostic value of plasma N-terminal pro-brain natriuretic peptide in children with congenital heart defects and open-heart surgery. J Pediatr 148: 372–376PubMedCrossRefGoogle Scholar
  20. 20.
    Kurotobi S, Kawakami N, Shimizu K, et al (2005) Brain natriuretic peptide as a hormonal marker of ventricular diastolic dysfunction in children with Kawasaki disease. Pediatr Cardiol 26: 425–430PubMedCrossRefGoogle Scholar
  21. 21.
    Lan YT, Chang RK, Alejos JC, Burch C, Wetzel GT (2004) B-type natriuretic peptide in children after cardiac transplantation. J Heart Lung Transplant 23: 558–563PubMedCrossRefGoogle Scholar
  22. 22.
    Suda K, Matsumura M, Matsumoto M (2003) Clinical implication of plasma natriuretic peptides in children with ventricular septal defect. Pediatr Int 45: 249–254PubMedCrossRefGoogle Scholar
  23. 23.
    Kunii Y, Kamada M, Ohtsuki S, et al (2003) Plasma brain natriuretic peptide and the evaluation of volume overload in infants and children with congenital heart disease. Acta Med Okayama 57: 191–197PubMedGoogle Scholar
  24. 24.
    Koch A, Zink S, Singer H (2006) B-type natriuretic peptide in paediatric patients with congenital heart disease. Eur Heart J 27: 861–866PubMedCrossRefGoogle Scholar
  25. 25.
    Koch AM, Rauh M, Zink S, Singer H (2006) Decreasing ratio of plasma N-terminal pro-B-type natriuretic peptide and B-type natriuretic peptide according to age. Acta Paediatr 95: 805–809PubMedCrossRefGoogle Scholar
  26. 26.
    Price JF, Thomas AK, Grenier M, et al (2006) B-type natriuretic peptide predicts adverse cardiovascular events in pediatric outpatients with chronic left ventricular systolic dysfunction. Circulation 114: 1063–1069PubMedCrossRefGoogle Scholar
  27. 27.
    Sun LS, Dominguez C, Mallavaram NA, Quaegebeur JM (2005) Dysfunction of atrial and B-type natriuretic peptides in congenital univentricular defects, J Thorac Cardiovasc Surg 129: 1104–1110PubMedCrossRefGoogle Scholar
  28. 28.
    Ationu A, Singer DR, Smith A, Elliott M, Burch M, Carter ND (1993) Studies of cardiopulmonary bypass in children: implications for the regulation of brain natriuretic peptide. Cardiovasc Res 27: 1538–1541PubMedCrossRefGoogle Scholar
  29. 29.
    Costello JM, Backer CL, Checchia PA, Mavroudis C, Seipelt RG, Goodman DM (2004) Alterations in the natriuretic hormone system related to cardiopulmonary bypass in infants with congestive heart failure. Pediatr Cardiol 25: 347–353PubMedCrossRefGoogle Scholar
  30. 30.
    Shih CY, Sapru A, Oishi P, et al (2006) Alterations in plasma B-type natriuretic peptide levels after repair of congenital heart defects: a potential perioperative marker. J Thorac Cardiovasc Surg 131: 632–638PubMedCrossRefGoogle Scholar
  31. 31.
    Hsu J, Keller R, Chikovani O, et al (2007) B-type natriuretic peptide levels predict outcome after neonatal cardiac surgery. J Thorac Cardiovasc Surg 134: 939–945PubMedCrossRefGoogle Scholar
  32. 32.
    Cannesson M, Bionda C, Gostoli B, et al (2007) Time course and prognostic value of plasma B-type natriuretic peptide concentration in neonates undergoing the arterial switch operation. Anesth Analg 104: 1059–1065PubMedCrossRefGoogle Scholar
  33. 33.
    Berry JG, Askovich B, Shaddy RE, Hawkins JA, Cowley CG (2007) Prognostic value of B-type natriuretic peptide in surgical palliation of children with single-ventricle congenital heart disease. Pediatr Cardiol [Epub ahead of print]Google Scholar
  34. 34.
    Chikovani O, Hsu J, Keller R, et al (2007) B-type natriuretic peptide levels predict outcomes for children on extracorporeal life support after cardiac surgery. J Thorac Cardiovasc Surg 134: 1179–1187PubMedCrossRefGoogle Scholar
  35. 35.
    Huang SC, Wu ET, Ko WJ, et al (2006) Clinical implication of blood levels of B-type natriuretic peptide in pediatric patients on mechanical circulatory support. Ann Thorac Surg 81: 2267–2272PubMedCrossRefGoogle Scholar
  36. 36.
    Reynolds EW, Ellington JG, Vranicar M, Bada HS (2004) Brain-type natriuretic peptide in the diagnosis and management of persistent pulmonary hypertension of the newborn. Pediatrics 114: 1297–1304PubMedCrossRefGoogle Scholar
  37. 37.
    Cohen S, Springer C, Avital A, Perles Z, Rein AJ, Argaman Z, Nir A (2005) Amino-terminal pro-brain-type natriuretic peptide: heart or lung disease in pediatric respiratory distress? Pediatrics 115: 1347–1350PubMedCrossRefGoogle Scholar
  38. 38.
    Koulouri S, Acherman RJ, Wong PC, Chan LS, Lewis AB (2004) Utility of B-type natriuretic peptide in differentiating congestive heart failure from lung disease in pediatric patients with respiratory distress. Pediatr Cardiol 25: 341–346PubMedCrossRefGoogle Scholar
  39. 39.
    Choi BM, Lee KH, Eun BL, et al (2005) Utility of rapid B-type natriuretic peptide assay for diagnosis of symptomatic patent ductus arteriosus in preterm infants. Pediatrics 115: e255–261PubMedCrossRefGoogle Scholar
  40. 40.
    Flynn PA, da Graca RL, Auld PA, Nesin M, Kleinman CS (2005) The use of a bedside assay for plasma B-type natriuretic peptide as a biomarker in the management of patent ductus arteriosus in premature neonates. J Pediatr 147: 38–42PubMedCrossRefGoogle Scholar
  41. 41.
    Puddy VF, Amirmansour C, Williams AF, Singer DR (2002) Plasma brain natriuretic peptide as a predictor of haemodynamically significant patent ductus arteriosus in preterm infants. Clin Sci (Lond) 103: 75–77Google Scholar
  42. 42.
    Sanjeev S, Pettersen M, Lua J, Thomas R, Shankaran S, L’Ecuyer T (2005) Role of plasma B-type natriuretic peptide in screening for hemodynamically significant patent ductus arteriosus in preterm neonates. J Perinatol 25: 709–713PubMedCrossRefGoogle Scholar
  43. 43.
    Holmstrom H, Omland T (2002) Natriuretic peptides as markers of patent ductus arteriosus in preterm infants. Clin Sci (Lond) 103: 79–80CrossRefGoogle Scholar
  44. 44.
    da Graca RL, Hassinger DC, Flynn PA, Sison CP, Nesin M, Auld PA (2006) Longitudinal changes of brain-type natriuretic peptide in preterm neonates. Pediatrics 117: 2183–2189PubMedCrossRefGoogle Scholar
  45. 45.
    Fried I, Bar-Oz B, Algur N, et al (2006) Comparison of N-terminal pro-B-type natriuretic peptide levels in critically ill children with sepsis versus acute left ventricular dysfunction. Pediatrics 118: e1165–1168PubMedCrossRefGoogle Scholar
  46. 46.
    Kaditis AG, Alexopoulos EI, Hatzi F, et al (2006) Overnight change in brain natriuretic peptide levels in children with sleep-disordered breathing. Chest 130: 1377–1384PubMedCrossRefGoogle Scholar
  47. 47.
    Erkus B, Demirtas S, Yarpuzlu AA, Can M, Genc Y, Karaca L (2007) Early prediction of anthracycline induced cardiotoxicity. Acta Paediatr 96: 506–509PubMedCrossRefGoogle Scholar
  48. 48.
    Aggarwal S, Pettersen MD, Bhambhani K, Gurczynski J, Thomas R, L’Ecuyer T (2007) B-type natriuretic peptide as a marker for cardiac dysfunction in anthracycline-treated children. Pediatr Blood Cancer 49: 812–816PubMedCrossRefGoogle Scholar
  49. 49.
    Rauchenzauner M, Haberlandt E, Foerster S, et al (2007) Brain-type natriuretic peptide secretion following febrile and afebrile seizures — a new marker in childhood epilepsy? Epilepsia 48: 101–106PubMedGoogle Scholar

Copyright information

© Springer Science + Business Media Inc. 2008

Authors and Affiliations

  • P. E. Oishi
    • 1
  • J. -H. Hsu
    • 2
  • J. R. Fineman
    • 1
  1. 1.Pediatric Critical CareUniversity of CaliforniaSan FranciscoUSA
  2. 2.Department of Pediatrics Kaohsiung MedicalUniversity HospitalKaohsiungTaiwan

Personalised recommendations